Sanofi-aventis CEO Chris Viehbacher and Sanofi Pasteur President and CEO Wayne Pisano plan to discuss the challenges of manufacturing H1N1, or swine flu, vaccine, during a webcast conference starting at 2:30 p.m. ET Wednesday, Nov. 11. David Greenberg, senior director of scientific and medical affairs at Sanofi Pasteur, will provide new data from adult and pediatric clinical trials of the U.S. licensed vaccine.
Sanofi execs to discuss vaccine production
Send us a letter